Scientists Don’t Fear a New Crispr Snag – Asharq Al-awsat English
|
Scientists Don't Fear a New Crispr Snag
Asharq Al-awsat English Porteus himself is working with FDA to start clinical trials of a Crispr-based therapy for sickle cell disease. The key difference between Crispr and more traditional gene therapy, he said, is in its precision. The original version of gene therapy … |
